Valuation: Sight Sciences, Inc.

Market Cap 448M 388M 366M 332M 623M 42.93B 628M 4.37B 1.69B 21.78B 1.68B 1.65B 69.23B P/E 2026 *
-14x
P/E 2027 * -17.5x
Enterprise Value 410M 355M 335M 304M 571M 39.31B 575M 4.01B 1.54B 19.94B 1.54B 1.51B 63.4B EV / Sales 2026 *
4.54x
EV / Sales 2027 * 4.16x
Free-Float
79.94%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-2.63%
Current month-4.35%
1 month-0.12%
3 months+58.48%
6 months+121.53%
Current year+2.52%
1 week 7.7
Extreme 7.7
8.32
1 month 7.7
Extreme 7.7
8.85
Current year 3.38
Extreme 3.378
8.85
1 year 3.19
Extreme 3.19
9.24
3 years 1.04
Extreme 1.04
9.24
5 years 1.04
Extreme 1.04
29.5
10 years 1.04
Extreme 1.04
42.57
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 56 01/01/2010
Chief Executive Officer 51 01/01/2010
Director of Finance/CFO 43 05/11/2025
Director TitleAgeSince
Director/Board Member 51 01/01/2010
Director/Board Member 56 01/01/2010
Chairman 74 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
8/10/26 A Free

General Counsel

181,818 0.3342%
7/6/26 A Sell

Founder

-7,418 0.0136%
7/6/26 A Sell

General Counsel

-12,733 0.0234%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-2.63%+134.97%+132.95% 448M
+1.12%-4.84%-22.91%+0.43% 178B
+3.12%-0.39%-0.24%+14.45% 120B
+1.45%-1.43%+7.84%+84.32% 62.25B
-0.45%-4.27%+3.07%+33.55% 48.54B
+2.85%-0.99%-2.10%-30.88% 49.82B
+1.99%-3.66%+11.10%-16.61% 31.95B
+0.18%-10.93% - - 28.59B
+2.59%+4.48%+40.12%-10.73% 25B
-0.88%-3.61%-11.03%+1.86% 21.59B
Average +1.19%-3.48%+17.87%+23.26% 56.66B
Weighted average by Cap. +1.59%-3.32%-4.47%+11.99%

Financials

2026 *2027 *
Net sales 90.35M 78.29M 73.88M 67.03M 126M 8.66B 127M 882M 340M 4.39B 339M 332M 13.97B 101M 87.57M 82.64M 74.97M 141M 9.69B 142M 987M 380M 4.91B 380M 371M 15.62B
Net income -33.35M -28.9M -27.27M -24.74M -46.41M -3.2B -46.75M -326M -126M -1.62B -125M -122M -5.16B -28.58M -24.77M -23.37M -21.2M -39.77M -2.74B -40.06M -279M -108M -1.39B -107M -105M -4.42B
Net Debt -37.73M -32.69M -30.85M -27.99M -52.51M -3.62B -52.89M -368M -142M -1.83B -142M -139M -5.83B -27.73M -24.03M -22.68M -20.57M -38.59M -2.66B -38.87M -271M -104M -1.35B -104M -102M -4.29B
Logo Sight Sciences, Inc.
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Employees
186
Date Price Change Volume
14/09/26 $8.130 -0.12% 120,720
11/09/26 $8.140 +1.69% 179,559
10/09/26 $8.005 -0.56% 167,814
09/09/26 $8.050 -0.62% 167,160
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
8.130USD
Average target price
9.000USD
Spread / Average Target
+10.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SGHT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!